Asian Venture Capital Journal (AVCJ)
Singapore’s Asia Partners has closed its debut Southeast Asia VC fund at $384 million, describing it as the largest-ever first-time technology vehicle focused on the region.
SciClone Pharmaceuticals, a Chinese drug developer privatized by a PE consortium at a valuation of $605 million in 2017, has relisted in Hong Kong and ended its first day of trading with a market capitalization of HK$12.7 billion ($1.64 billion).
Iluvatar CoreX, a Shanghai-based computing chip designer has raised RMB1.2 billion ($186 million) in Series C funding led by Cedarlake Capital and Centurium Capital.
A darker mood for Chinese investors in India is stirring expectations for a wave of direct secondary opportunities
Affirma Capital came into being 18 months ago as Standard Chartered’s private equity team spun out with most of the remaining balance sheet assets. COO Ivo Philipps explains the middle and back office transition
Singapore’s Gushcloud, a VC-backed influencer talent agency and content producer, operates at the frontlines of a young, fast-changing media landscape. CEO Althea Lim tours the latest developments